What Is Prolozone Therapy

Prolozone therapy is a regenerative injection technique that combines medical-grade ozone (O₃) with a nutrient solution, typically including B vitamins, procaine, and sometimes dextrose, delivered directly into damaged or painful joints, ligaments, or tendons. The term was coined by Dr. Frank Shallenberger and blends "prolotherapy" with "ozone." The treatment aims to reduce pain and stimulate local tissue repair by improving cellular oxygen metabolism and modulating inflammation at the injection site.

Joint and connective tissue degeneration is one of the primary drivers of functional decline with aging. Cartilage, tendons, and ligaments have limited blood supply, which slows their regenerative capacity and makes them vulnerable to cumulative wear. Chronic musculoskeletal pain frequently leads to reduced physical activity, loss of muscle mass, impaired balance, and a self-reinforcing cycle of immobility and further degeneration. Any intervention that can meaningfully preserve or restore joint function has direct implications for maintaining the movement capacity that underlies broader healthspan.

Prolozone therapy sits within a family of regenerative injection therapies that attempt to activate local repair pathways rather than simply suppress pain signals. In the longevity context, this approach is relevant because it targets a root-level tissue problem (degenerated or poorly oxygenated connective tissue) rather than masking symptoms with chronic anti-inflammatory or analgesic use. Maintaining structural integrity in load-bearing joints directly supports the ability to continue resistance training, walking, and balance work well into later decades.

The prolozone injection protocol involves two phases delivered in a single session. First, a liquid solution containing a local anesthetic (usually procaine or lidocaine), B vitamins (commonly B12 and folic acid), and sometimes a small amount of dextrose is injected into and around the target tissue. The anesthetic provides immediate pain relief and helps reset abnormal pain signaling in the area. The B vitamins serve as cofactors for cellular metabolism. If dextrose is included, it provides a mild proliferative stimulus similar to standard prolotherapy.

The second phase introduces ozone gas (a mixture of O₂ and O₃) into the same area through the needle. Ozone is a highly reactive molecule that rapidly breaks down into reactive oxygen species. At therapeutic concentrations, these reactive species are believed to trigger a localized oxidative stress signal that upregulates antioxidant enzymes such as superoxide dismutase and glutathione peroxidase. This hormetic stimulus may activate local growth factor release, improve microcirculation, and enhance mitochondrial function in the surrounding cells.

The combined effect of improved oxygenation, nutrient delivery, and a controlled regenerative stimulus is thought to create conditions favorable for connective tissue repair. Ozone also has documented antimicrobial properties, which may help address low-grade infections that can contribute to chronic joint inflammation. The treatment differs from corticosteroid injections, which suppress inflammation but can weaken tissue structure over time. Prolozone, in contrast, aims to strengthen and rebuild the affected tissue, though the degree to which it achieves this in humans remains an area of ongoing investigation.

A prolozone session begins with a clinical assessment of the painful area, which may include range-of-motion testing and palpation to identify the specific structures involved. The skin over the injection site is cleaned, and the practitioner inserts a needle into the joint space or periarticular soft tissue. The nutrient and anesthetic solution is injected first, followed by a measured volume of ozone gas through the same needle or a second entry point. Patients often feel a sensation of pressure or mild distension as the gas enters the tissue.

The entire procedure typically takes 15 to 30 minutes per site, though the total appointment may be longer if multiple areas are treated or if consultation is included. Most patients experience immediate pain relief from the anesthetic component, which fades over several hours. A secondary wave of improvement, attributed to the ozone and nutrient effects, may develop over the following one to three weeks. Some patients notice increased soreness for the first day or two before improvement begins. Activity modification, rather than strict rest, is generally recommended in the days following treatment.

The standard initial course is three to six sessions, spaced two to four weeks apart. Practitioners typically reassess progress after the third session to determine whether additional treatments are warranted. Some patients with mild conditions report satisfactory results after as few as two sessions, while chronic or severely degenerated joints may require six or more. Each session treats one or several sites depending on the clinical situation.

After the initial course, some patients return for periodic maintenance injections every three to six months, particularly for joints subject to ongoing mechanical stress. Others find that the benefits are sustained without further treatment. The response pattern varies significantly between individuals and depends on factors such as the degree of tissue damage, nutritional status, and the biomechanical loads placed on the treated structures.

Prolozone therapy is typically not covered by insurance and is paid out of pocket. Per-session costs generally range from $150 to $500, depending on the number of sites treated, the practitioner's experience, and geographic location. A full initial course of three to six sessions may therefore total $450 to $3,000. Some clinics offer package pricing that reduces the per-session cost. Patients should confirm whether the quoted price includes the clinical assessment, the injection materials, and any follow-up consultations, as these may be billed separately at some practices.

The clinical evidence for prolozone therapy is limited and weighted toward lower tiers of the evidence hierarchy. Several case series and small observational studies have reported significant pain reduction and functional improvement in patients with knee osteoarthritis, low back pain, and shoulder injuries. A small number of controlled trials comparing prolozone to placebo or other interventions exist, with some showing favorable outcomes for pain scores at short- to medium-term follow-up. However, these studies generally involve small sample sizes, lack standardized protocols, and often do not include long-term follow-up or objective imaging to confirm tissue regeneration.

The broader ozone therapy literature provides mechanistic support for the approach. Animal and in vitro studies demonstrate that ozone at controlled concentrations can stimulate antioxidant enzyme production, reduce inflammatory cytokines, and enhance collagen synthesis. However, extrapolating these findings to the specific prolozone protocol in human joints requires caution. No large-scale, multicenter randomized controlled trials have been published as of now, and prolozone therapy remains outside the scope of most conventional orthopedic guidelines. The therapy is practiced predominantly within integrative, naturopathic, and functional medicine settings.

The most common side effects are temporary soreness, swelling, and bruising at the injection site, which typically resolve within a few days. Rare but serious risks include infection, nerve damage, and pneumothorax if injections are performed near the thoracic region by an inexperienced practitioner. Individuals with G6PD deficiency must avoid ozone therapy entirely due to the risk of hemolysis. The use of ozone in medical settings is not approved by the FDA, and regulatory status varies by jurisdiction. Patients should verify practitioner training and experience, particularly in ozone-specific injection techniques, before undergoing treatment.